Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Accenture
Colorcon
Baxter
Express Scripts
Novartis
Queensland Health
Boehringer Ingelheim
Covington

Generated: January 20, 2018

DrugPatentWatch Database Preview

Triflupromazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for triflupromazine hydrochloride and what is the scope of triflupromazine hydrochloride freedom to operate?

Triflupromazine hydrochloride
is the generic ingredient in one branded drug marketed by Apothecon and Bristol Myers Squibb, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for triflupromazine hydrochloride.
Summary for triflupromazine hydrochloride

US Patents and Regulatory Information for triflupromazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Dow
UBS
AstraZeneca
Merck
Fuji
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot